# A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1

> **NCT00239187** · PHASE1 · COMPLETED · sponsor: **OPKO Health, Inc.** · enrollment: 30 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** E1 and G1

## Key facts

- **NCT ID:** NCT00239187
- **Lead sponsor:** OPKO Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2007-01
- **Target enrollment:** 30 (—)
- **Last updated:** 2019-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239187, "A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00239187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*